Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Maximizing Recovery From Concussions for Youth Participating in Sports and Recreational Activities.

Murata NM, Oshiro R, Furutani T, Tsushima WT.

Am J Phys Med Rehabil. 2019 Jan;98(1):73-80. doi: 10.1097/PHM.0000000000001015.

PMID:
30096054
2.

Demographic transition and factors associated with remaining in place after the 2011 Fukushima nuclear disaster and related evacuation orders.

Morita T, Nomura S, Furutani T, Leppold C, Tsubokura M, Ozaki A, Ochi S, Kami M, Kato S, Oikawa T.

PLoS One. 2018 Mar 14;13(3):e0194134. doi: 10.1371/journal.pone.0194134. eCollection 2018.

3.

Impacts of the 2011 Fukushima nuclear accident on emergency medical service times in Soma District, Japan: a retrospective observational study.

Morita T, Tsubokura M, Furutani T, Nomura S, Ochi S, Leppold C, Takahara K, Shimada Y, Fujioka S, Kami M, Kato S, Oikawa T.

BMJ Open. 2016 Sep 28;6(9):e013205. doi: 10.1136/bmjopen-2016-013205.

4.

Estimated association between dwelling soil contamination and internal radiation contamination levels after the 2011 Fukushima Daiichi nuclear accident in Japan.

Tsubokura M, Nomura S, Sakaihara K, Kato S, Leppold C, Furutani T, Morita T, Oikawa T, Kanazawa Y.

BMJ Open. 2016 Jun 29;6(6):e010970. doi: 10.1136/bmjopen-2015-010970.

5.

Compliance with the proper use of an individual radiation dosimeter among children and the effects of improper use on the measured dose: a retrospective study 18-20 months following Japan's 2011 Fukushima nuclear incident.

Nomura S, Tsubokura M, Hayano R, Yoneoka D, Ozaki A, Shimada Y, Furutani T, Kanazawa Y, Oikawa T.

BMJ Open. 2015 Dec 30;5(12):e009555. doi: 10.1136/bmjopen-2015-009555.

6.

Dependence of radiation dose on the behavioral patterns among school children: a retrospective analysis 18 to 20 months following the 2011 Fukushima nuclear incident in Japan.

Nomura S, Tsubokura M, Furutani T, Hayano RS, Kami M, Kanazawa Y, Oikawa T.

J Radiat Res. 2016 Jan;57(1):1-8. doi: 10.1093/jrr/rrv051. Epub 2015 Nov 25.

7.

Correction: The Thyroid Status of Children and Adolescents in Fukushima Prefecture Examined during 20-30 Months after the Fukushima Nuclear Power Plant Disaster: A Cross-Sectional, Observational Study.

Watanobe H, Furutani T, Nihei M, Sakuma Y, Yanai R, Takahashi M, Sato H, Sagawa F.

PLoS One. 2015 Jul 15;10(7):e0133345. doi: 10.1371/journal.pone.0133345. eCollection 2015. No abstract available.

8.

Comparison between direct measurements and modeled estimates of external radiation exposure among school children 18 to 30 months after the Fukushima nuclear accident in Japan.

Nomura S, Tsubokura M, Hayano R, Furutani T, Yoneoka D, Kami M, Kanazawa Y, Oikawa T.

Environ Sci Technol. 2015 Jan 20;49(2):1009-16.

PMID:
25514624
9.

The thyroid status of children and adolescents in Fukushima Prefecture examined during 20-30 months after the Fukushima nuclear power plant disaster: a cross-sectional, observational study.

Watanobe H, Furutani T, Nihei M, Sakuma Y, Yanai R, Takahashi M, Sato H, Sagawa F.

PLoS One. 2014 Dec 4;9(12):e113804. doi: 10.1371/journal.pone.0113804. eCollection 2014. Erratum in: PLoS One. 2015;10(7):e0133345.

10.

Growth arrest and DNA damage-inducible 34 regulates liver regeneration in hepatic steatosis in mice.

Inaba Y, Furutani T, Kimura K, Watanabe H, Haga S, Kido Y, Matsumoto M, Yamamoto Y, Harada K, Kaneko S, Oyadomari S, Ozaki M, Kasuga M, Inoue H.

Hepatology. 2015 Apr;61(4):1343-56. doi: 10.1002/hep.27619. Epub 2015 Feb 23.

PMID:
25420998
11.

Enhancement of RNA annealing and strand displacement found in archaeal ribonuclease P proteins is conserved in Escherichia coli protein C5 and yeast protein Rpr2.

Furutani T, Hazeyama K, Ueda T, Tomita S, Imai T, Nakashima T, Kakuta Y, Kimura M.

Biosci Biotechnol Biochem. 2014;78(10):1700-2. doi: 10.1080/09168451.2014.925780. Epub 2014 Jun 26.

PMID:
25273134
12.

In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3).

Kikuchi A, Furutani T, Azami H, Watanabe K, Niimi T, Kamiyama Y, Kuromitsu S, Baskin-Bey E, Heeringa M, Ouatas T, Enjo K.

Invest New Drugs. 2014 Oct;32(5):860-70. doi: 10.1007/s10637-014-0130-5. Epub 2014 Jul 1.

PMID:
24981575
13.

The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice.

Mori M, Ueno Y, Konagai S, Fushiki H, Shimada I, Kondoh Y, Saito R, Mori K, Shindou N, Soga T, Sakagami H, Furutani T, Doihara H, Kudoh M, Kuromitsu S.

Mol Cancer Ther. 2014 Feb;13(2):329-40. doi: 10.1158/1535-7163.MCT-13-0395. Epub 2014 Jan 13.

14.

Limited internal radiation exposure associated with resettlements to a radiation-contaminated homeland after the Fukushima Daiichi nuclear disaster.

Tsubokura M, Kato S, Nihei M, Sakuma Y, Furutani T, Uehara K, Sugimoto A, Nomura S, Hayano R, Kami M, Watanobe H, Endo Y.

PLoS One. 2013 Dec 2;8(12):e81909. doi: 10.1371/journal.pone.0081909. eCollection 2013.

15.

Discovery of 2-methyl-1-{1-[(5-methyl-1H-indol-2-yl)carbonyl]piperidin-4-yl}propan-2-ol: a novel, potent and selective type 5 17β-hydroxysteroid dehydrogenase inhibitor.

Watanabe K, Kakefuda A, Yasuda M, Enjo K, Kikuchi A, Furutani T, Naritomi Y, Otsuka Y, Okada M, Ohta M.

Bioorg Med Chem. 2013 Sep 1;21(17):5261-70. doi: 10.1016/j.bmc.2013.06.025. Epub 2013 Jun 19.

PMID:
23845281
16.

Molecular cloning and tissue distribution of cholecystokinin-1 receptor (CCK-1R) in yellowtail Seriola quinqueradiata and its response to feeding and in vitro CCK treatment.

Furutani T, Masumoto T, Fukada H.

Gen Comp Endocrinol. 2013 Jun 1;186:1-8. doi: 10.1016/j.ygcen.2013.02.003. Epub 2013 Mar 4.

PMID:
23467070
17.

[A case of extrahepatic bile duct metastasis from gastric cancer].

Satake M, Furutani T, Ozawa H, Konishi T, Yasunaga M.

Nihon Shokakibyo Gakkai Zasshi. 2013 Mar;110(3):412-8. Japanese.

PMID:
23459535
18.

Zebrafish respond to the geomagnetic field by bimodal and group-dependent orientation.

Takebe A, Furutani T, Wada T, Koinuma M, Kubo Y, Okano K, Okano T.

Sci Rep. 2012;2:727. doi: 10.1038/srep00727. Epub 2012 Oct 11.

19.

Yellowtail insulin-like growth factor 1: molecular cloning and response to various nutritional conditions.

Fukada H, Murashita K, Furutani T, Masumoto T.

Domest Anim Endocrinol. 2012 May;42(4):220-9. doi: 10.1016/j.domaniend.2011.12.005. Epub 2012 Jan 5.

PMID:
22265757
20.

A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice.

Korenaga M, Hidaka I, Nishina S, Sakai A, Shinozaki A, Gondo T, Furutani T, Kawano H, Sakaida I, Hino K.

Liver Int. 2011 Apr;31(4):552-60. doi: 10.1111/j.1478-3231.2011.02469.x. Epub 2011 Feb 15.

PMID:
21382166
21.

Current organic waste recycling and the potential for local recycling through urban agriculture in Metro Manila.

Hara Y, Furutani T, Murakami A, Palijon AM, Yokohari M.

Waste Manag Res. 2011 Nov;29(11):1213-21. doi: 10.1177/0734242X10386638. Epub 2010 Oct 15.

PMID:
20952443
22.

Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity.

Suzuki E, Zhao Y, Ito S, Sawatsubashi S, Murata T, Furutani T, Shirode Y, Yamagata K, Tanabe M, Kimura S, Ueda T, Fujiyama S, Lim J, Matsukawa H, Kouzmenko AP, Aigaki T, Tabata T, Takeyama K, Kato S.

Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3818-22. doi: 10.1073/pnas.0809819106. Epub 2009 Feb 23. Erratum in: Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16393.

23.

RNA-binding protein hoip accelerates polyQ-induced neurodegeneration in Drosophila.

Murata T, Suzuki E, Ito S, Sawatsubashi S, Zhao Y, Yamagata K, Tanabe M, Fujiyama S, Kimura S, Ueda T, Matsukawa H, Kouzmenko A, Furutani T, Kuranaga E, Miura M, Takeyama K, Kato S.

Biosci Biotechnol Biochem. 2008 Sep;72(9):2255-61. Epub 2008 Sep 7.

24.

Improvement of substrate conversion to molecular hydrogen by three-stage cultivation of a photosynthetic bacterium, Rhodovulum sulfidophilum.

Maeda I, Chowdhury WQ, Idehara K, Yagi K, Mizoguchi T, Akano T, Mlyasaka H, Furutani T, Ikuta Y, Shioji N, Miura Y.

Appl Biochem Biotechnol. 1998 Spring;70-72:301-10. doi: 10.1007/BF02920146.

PMID:
18575999
25.

Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription.

Nishina S, Hino K, Korenaga M, Vecchi C, Pietrangelo A, Mizukami Y, Furutani T, Sakai A, Okuda M, Hidaka I, Okita K, Sakaida I.

Gastroenterology. 2008 Jan;134(1):226-38. doi: 10.1053/j.gastro.2007.10.011. Epub 2007 Oct 9.

PMID:
18166355
26.

Alpha-tocopherol [corrected] and ascorbic acid attenuates the ribavirin [corrected] induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients.

Hino K, Murakami Y, Nagai A, Kitase A, Hara Y, Furutani T, Ren F, Yamaguchi Y, Yutoku K, Yamashita S, Okuda M, Okita M, Okita K.

J Gastroenterol Hepatol. 2006 Aug;21(8):1269-75. Erratum in: J Gastroenterol Hepatol. 2006 Oct;21(10):1640.

PMID:
16872308
27.

Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.

Furutani T, Hino K, Okuda M, Gondo T, Nishina S, Kitase A, Korenaga M, Xiao SY, Weinman SA, Lemon SM, Sakaida I, Okita K.

Gastroenterology. 2006 Jun;130(7):2087-98.

PMID:
16762631
28.

Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species.

Hara Y, Hino K, Okuda M, Furutani T, Hidaka I, Yamaguchi Y, Korenaga M, Li K, Weinman SA, Lemon SM, Okita K.

J Gastroenterol. 2006 Mar;41(3):257-68.

PMID:
16699860
29.

(+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.

Kinoyama I, Taniguchi N, Toyoshima A, Nozawa E, Kamikubo T, Imamura M, Matsuhisa A, Samizu K, Kawanimani E, Niimi T, Hamada N, Koutoku H, Furutani T, Kudoh M, Okada M, Ohta M, Tsukamoto S.

J Med Chem. 2006 Jan 26;49(2):716-26.

PMID:
16420057
30.

A role of androgen receptor protein in cell growth of an androgen-independent prostate cancer cell line.

Furutani T, Takeyama K, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, Kato S.

Biosci Biotechnol Biochem. 2005 Nov;69(11):2236-9.

31.

Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target.

Furutani T, Takeyama K, Tanabe M, Koutoku H, Ito S, Taniguchi N, Suzuki E, Kudoh M, Shibasaki M, Shikama H, Kato S.

J Pharmacol Exp Ther. 2005 Nov;315(2):545-52. Epub 2005 Aug 3. Retraction in: J Pharmacol Exp Ther. 2014 Mar;348(3):493.

PMID:
16079302
32.

In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis.

Kitase A, Hino K, Furutani T, Okuda M, Gondo T, Hidaka I, Hara Y, Yamaguchi Y, Okita K.

J Gastroenterol. 2005 Jun;40(6):617-24.

PMID:
16007396
33.

N-Arylpiperazine-1-carboxamide derivatives: a novel series of orally active nonsteroidal androgen receptor antagonists.

Kinoyama I, Taniguchi N, Kawaminami E, Nozawa E, Koutoku H, Furutani T, Kudoh M, Okada M.

Chem Pharm Bull (Tokyo). 2005 Apr;53(4):402-9.

34.

Synthesis and pharmacological evaluation of novel arylpiperazine derivatives as nonsteroidal androgen receptor antagonists.

Kinoyama I, Taniguchi N, Yoden T, Koutoku H, Furutani T, Kudoh M, Okada M.

Chem Pharm Bull (Tokyo). 2004 Nov;52(11):1330-3.

35.

Wnt/beta-catenin and estrogen signaling converge in vivo.

Kouzmenko AP, Takeyama K, Ito S, Furutani T, Sawatsubashi S, Maki A, Suzuki E, Kawasaki Y, Akiyama T, Tabata T, Kato S.

J Biol Chem. 2004 Sep 24;279(39):40255-8. Epub 2004 Aug 9.

36.

Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila.

Takeyama K, Ito S, Yamamoto A, Tanimoto H, Furutani T, Kanuka H, Miura M, Tabata T, Kato S.

Neuron. 2002 Aug 29;35(5):855-64.

37.
38.

Stabilization of androgen receptor protein is induced by agonist, not by antagonists.

Furutani T, Watanabe T, Tanimoto K, Hashimoto T, Koutoku H, Kudoh M, Shimizu Y, Kato S, Shikama H.

Biochem Biophys Res Commun. 2002 Jun 21;294(4):779-84.

PMID:
12061774
39.

An efficient synthesis of C2-symmetric chiral binaphthyl ketone catalysts.

Furutani T, Hatsuda M, Shimizu T, Seki M.

Biosci Biotechnol Biochem. 2001 Jan;65(1):180-4.

40.

[Detection of Ki-67 in liver biopsy specimens using monoclonal antibody to Mib-1].

Matsumoto K, Tanimoto K, Michitaka K, Furutani T, Nakaya M, Horiike N, Onji M.

Rinsho Byori. 1999 Oct;47(10):956-60. Japanese.

PMID:
10590670
41.

Acyl amino acid derivatives as novel inhibitors of influenza neuraminidase.

Kondoh M, Furutani T, Azuma M, Ooshima H, Kato J.

Biosci Biotechnol Biochem. 1997 May;61(5):870-4.

42.

Inhibition of octapeptide N-myristoylation by acyl amino acids and acyl alkanolamines.

Tabuchi M, Okamoto H, Furutani T, Azuma M, Ooshima H, Otake T, Kawahata T, Kato J.

J Enzyme Inhib. 1997 Apr;12(1):27-36.

PMID:
9204380
43.

Immunogenicity and safety of an attenuated Bordetella bronchiseptica vaccine in pigs.

Sakano T, Sakurai K, Furutani T, Shimizu T.

Am J Vet Res. 1984 Sep;45(9):1814-7.

PMID:
6497138
44.

Resistance of chickens to Newcastle disease virus after inoculation with the B1 and Mukteswar strains and prior to production of neutralizing antibody.

Watanabe M, Furutani T, Nishimura Y.

Natl Inst Anim Health Q (Tokyo). 1968 Summer;8(2):112-3. No abstract available.

PMID:
5712542
45.

FOOT-AND-MOUTH DISEASE (EPIZOOTIOLOGY AND PROPHYLAXIS) IN INDIA.

THONN S, FOGH JM, FURUTANI T.

Bull Off Int Epizoot. 1965 Jan-Feb;63:3-8. No abstract available.

PMID:
14298855
46.

[THE PRESENT SITUATION OF CATTLE PLAGUE IN CAMBODIA AND ITS PREVENTION IN RECENT YEARS].

THONN S, FOGH JM, FURUTANI T.

Bull Off Int Epizoot. 1965 Jan-Feb;63:35-44. French. No abstract available.

PMID:
14298854
47.

[Studies on the avianized variants of rinderpest virus].

FURUTANI T.

Nihon Densenbyo Gakkai Zasshi. 1961 Jul;35:299-323. Japanese. No abstract available.

PMID:
13702708

Supplemental Content

Loading ...
Support Center